Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ISRG | Common Stock | Options Exercise | $37.8K | +156 | +20.47% | $242.34 | 918 | Oct 22, 2021 | Direct | F1, F2 |
transaction | ISRG | Common Stock | Sale | -$53K | -156 | -16.99% | $339.71 | 762 | Oct 22, 2021 | Direct | F1, F2, F3 |
transaction | ISRG | Common Stock | Options Exercise | $27.8K | +156 | +20.47% | $177.99 | 918 | Oct 22, 2021 | Direct | F1, F2 |
transaction | ISRG | Common Stock | Sale | -$53K | -156 | -16.99% | $339.66 | 762 | Oct 22, 2021 | Direct | F1, F2, F4 |
transaction | ISRG | Common Stock | Options Exercise | $45.5K | +273 | +35.83% | $166.62 | 1.04K | Oct 22, 2021 | Direct | F1, F2 |
transaction | ISRG | Common Stock | Sale | -$92.7K | -273 | -26.38% | $339.66 | 762 | Oct 22, 2021 | Direct | F1, F2, F4 |
transaction | ISRG | Common Stock | Options Exercise | $49.9K | +273 | +35.83% | $182.83 | 1.04K | Oct 22, 2021 | Direct | F1, F2 |
transaction | ISRG | Common Stock | Sale | -$92.7K | -273 | -26.38% | $339.66 | 762 | Oct 22, 2021 | Direct | F1, F2, F4 |
transaction | ISRG | Common Stock | Options Exercise | $55.9K | +321 | +42.13% | $174.26 | 1.08K | Oct 22, 2021 | Direct | F1, F2 |
transaction | ISRG | Common Stock | Sale | -$109K | -321 | -29.64% | $339.66 | 762 | Oct 22, 2021 | Direct | F1, F2, F4 |
transaction | ISRG | Common Stock | Options Exercise | $45.2K | +324 | +42.52% | $139.52 | 1.09K | Oct 22, 2021 | Direct | F1, F2 |
transaction | ISRG | Common Stock | Sale | -$110K | -324 | -29.83% | $339.66 | 762 | Oct 22, 2021 | Direct | F1, F2, F4 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ISRG | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -324 | -42.86% | $0.00 | 432 | Oct 22, 2021 | Common Stock | 324 | $139.52 | Direct | F1, F2, F5 |
transaction | ISRG | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -273 | -15.85% | $0.00 | 1.45K | Oct 22, 2021 | Common Stock | 273 | $166.62 | Direct | F1, F2, F6 |
transaction | ISRG | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -321 | -42.63% | $0.00 | 432 | Oct 22, 2021 | Common Stock | 321 | $174.26 | Direct | F1, F2, F6 |
transaction | ISRG | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -156 | -9.3% | $0.00 | 1.52K | Oct 22, 2021 | Common Stock | 156 | $177.99 | Direct | F1, F2, F5 |
transaction | ISRG | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -273 | -15.85% | $0.00 | 1.45K | Oct 22, 2021 | Common Stock | 273 | $182.83 | Direct | F1, F2, F7 |
transaction | ISRG | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -156 | -9.34% | $0.00 | 1.52K | Oct 22, 2021 | Common Stock | 156 | $242.34 | Direct | F1, F2, F6 |
Id | Content |
---|---|
F1 | These shares were exercised and sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 8, 2021. |
F2 | On October 5, 2021, the common stock and equity grants of Intuitive Surgical split 3-for-1, resulting in the reporting person's ownership of the company's stock and equity grants to increase (for every one share owned or granted, 2 additional shares were issued) and the exercise price of stock option grants to decrease to 1/3rd of the original grant price. |
F3 | The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $338.64 to $341.03 as follows: 20 shares sold at $338.64 to $338.99; 106 shares sold at $339.06 to $339.98; 30 shares sold at $340.04 to $341.03. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
F4 | The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $338.47 to $341.34 as follows:179 shares sold at $338.47 to $338.99; 866 shares sold at $339 to $339.99; 280 shares sold at $340.09 to $340.82; 22 shares sold at $341 to $341.34. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
F5 | Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |
F6 | Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48th one month after the date of grant and 1/48th monthly thereafter. |
F7 | Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |